MiniMed Launches Compact Insulin Pump with Abbott’s Longest-Wear Sensor
Event summary
- MiniMed’s Flex™ system now ships with Abbott’s Instinct sensor, offering up to 15 days of wear.
- The app-controlled pump combines SmartGuard™ automation with Meal Detection™ technology.
- FDA-cleared for type 1 diabetes (ages 7+) and insulin-requiring type 2 diabetes (adults).
- MiniMed’s first major marketing campaign since the system’s U.S. launch earlier this summer.
The big picture
MiniMed’s integration with Abbott’s sensor extends wear time and reduces user burden, aligning with the broader trend toward seamless, automated diabetes management. The partnership underscores the industry’s shift toward modular, interoperable devices, potentially setting a new standard for insulin delivery systems. With real-world data showing high Time in Range metrics, the system could strengthen MiniMed’s market share in an increasingly competitive space.
What we're watching
- Market Adoption
- Whether the combination of MiniMed’s pump and Abbott’s sensor accelerates user migration from older systems.
- Competitive Dynamics
- How this partnership affects MiniMed’s positioning against rivals like Dexcom and Insulet.
- Regulatory Compliance
- The pace at which MiniMed can expand FDA clearance to additional demographics or geographies.
Related topics